The Market Reports

Synopsis

The global market for TMS (Transcranial Magnetic Stimulation) Coil was estimated to be worth US$ 29.9 million in 2024 and is forecast to a readjusted size of US$ 85.4 million by 2031 with a CAGR of 16.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on TMS (Transcranial Magnetic Stimulation) Coil cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

The Transcranial Magnetic Stimulation (TMS) Coil is the core component of TMS devices, responsible for generating rapidly changing magnetic fields that induce electric currents in cortical neurons to modulate brain activity non-invasively. Typically made from coiled conductive copper wire, TMS coils come in various forms such as figure-eight, circular, or H-shaped configurations, each offering different focality and stimulation depth. TMS Coils are widely used in psychiatric therapy (e.g., depression, anxiety), neurorehabilitation (e.g., post-stroke recovery, Parkinson’s disease), and neuroscience research. As precision medicine, personalized therapies, and mental health demands grow, TMS coils are increasingly transitioning from academic labs into routine clinical settings, becoming a key technological enabler in next-generation neuromodulation systems.In 2024, global Transcranial Magnetic Stimulation (TMS) Coil production reached approximately 5688 unit, with an average global market price of around US$ 5270/unit.
With rising global prevalence of mental health disorders and increasing demand for non-pharmacological interventions, TMS technology is gaining strong momentum across clinical and research sectors. As the core component of TMS devices, coil performance and cost efficiency play a critical role in treatment outcomes and device adoption. The continuous launch of next-generation coils featuring deep brain stimulation and multi-channel targeting is expanding therapeutic applications beyond depression to Alzheimer's, autism, and chronic pain. Meanwhile, favorable reimbursement policies in developed markets like the US and EU are encouraging hospitals, psychiatric clinics, and rehabilitation centers to procure TMS devices, driving substantial upstream demand for coils.

As a converter of electromagnetic energy, the TMS coil faces high technical barriers due to its complex design, heat tolerance requirements, and challenges in ensuring production consistency. Globally, most TMS device manufacturers rely on in-house or closed-loop coil supply chains, limiting entry opportunities for independent coil vendors. Although TMS coils are high-usage consumables, their replacement cycles and usage standards vary widely, creating discrepancies between actual demand and market size estimates. Additionally, tightening medical device regulations worldwide present hurdles in terms of prolonged certification cycles and rigorous validation protocols.

Downstream applications of TMS are rapidly expanding from psychiatry (primarily major depressive disorder) to rehabilitation medicine, pain management, and pediatric neurological disorders. Patient-centric care models are driving demand for customized coil designs and individualized stimulation protocols, positioning these as key differentiators among device manufacturers. The emergence of portable and home-use TMS devices is fueling growth in compact and lightweight coil demand. New buyer segments such as research institutes, startups, and outpatient chains are reshaping the market landscape, unlocking new growth potential for TMS coil suppliers.

This report aims to provide a comprehensive presentation of the global market for TMS (Transcranial Magnetic Stimulation) Coil, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of TMS (Transcranial Magnetic Stimulation) Coil by region & country, by Type, and by Application.

The TMS (Transcranial Magnetic Stimulation) Coil market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TMS (Transcranial Magnetic Stimulation) Coil.

Market Segmentation

By Company

• Magstim
• Neuronetics
• Brainsway
• MagVenture
• Yiruide
• Neurosoft
• Remed
• Nexstim
• MAG & More
• Deymed

Segment by Type

• Butterfly Coil
• Circular Coil
• Others

Segment by Application

• sTMS
• rTMS
• Others

Segment by Region

• North America: United States, Canada, and Mexico
• Europe: United Kingdom, Germany, France, Spain, Italy, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, and Rest of Asia Pacific
• Middle East & Africa: Saudi Arabia, South Africa, and Rest of MEA
• Latin America: Brazil, Argentina, and Rest of Latin America

*If you need a regional or country-specific version, or customized segmentation, we can tailor the report to your requirements.